Lactobacillus brevis CD2

Lactobacillus brevis CD2 is a probiotic strain that produces antimicrobial compounds including bacteriocins and hydrogen peroxide to inhibit pathogenic bacteria. It primarily works through competitive exclusion and immune modulation via toll-like receptor pathways.

Origin & History

Lactobacillus brevis CD2 is a probiotic strain known for its role in oral health and immune support. It is commonly found in fermented foods and supplements.

Historical & Cultural Context

Lactobacillus brevis is traditionally used in the fermentation of foods like sauerkraut and pickles. It has been valued for its health benefits in oral and immune health.

Health Benefits

- Supports oral health by reducing plaque formation, as evidenced by a study showing a 40% reduction in plaque index. This helps prevent cavities and gum disease. - Enhances immune function by boosting the production of natural killer cells, which play a critical role in fighting infections. - Reduces inflammation in the mouth, which can alleviate symptoms of gingivitis and other periodontal diseases. - Promotes gut health by increasing the diversity of beneficial bacteria, improving digestion and nutrient uptake. - Supports respiratory health by reducing the colonization of harmful bacteria in the respiratory tract, lowering infection risk. - Aids in mental clarity by producing neurotransmitters that enhance cognitive function and reduce stress. - Improves skin health by balancing the skin's microbiome, reducing acne and promoting a healthy complexion.

How It Works

Lactobacillus brevis CD2 produces bacteriocins and hydrogen peroxide that directly inhibit pathogenic bacteria through membrane disruption. It modulates immune function by activating toll-like receptors on dendritic cells, leading to enhanced natural killer cell production and cytokine release. The strain also competes for adhesion sites on mucosal surfaces, preventing pathogen colonization.

Scientific Research

Research indicates Lactobacillus brevis CD2 can support oral health and enhance the immune system. Studies also suggest its potential in reducing allergy symptoms.

Clinical Summary

A randomized controlled trial demonstrated a 40% reduction in plaque index scores after 4 weeks of supplementation with Lactobacillus brevis CD2. Immune function studies show increased natural killer cell activity in healthy adults taking 1×10⁹ CFU daily for 8 weeks. However, most research consists of small-scale studies with 30-60 participants, and larger long-term trials are needed to confirm therapeutic effects. The evidence is promising but still considered preliminary for most health claims.

Nutritional Profile

- Rich in probiotics. - Supports oral and immune health. - Enhances gut health.

Preparation & Dosage

Typical dosage is 1-10 billion CFUs per day. Consult a healthcare provider before use.

Synergy & Pairings

Vitamin D, Zinc, Lactobacillus rhamnosus

Safety & Interactions

Lactobacillus brevis CD2 is generally well-tolerated with mild gastrointestinal symptoms like bloating reported in less than 5% of users. No significant drug interactions have been documented, though it may theoretically reduce antibiotic effectiveness if taken simultaneously. Individuals with severe immunocompromised conditions should consult healthcare providers before use due to rare risk of bacteremia. Safety during pregnancy and breastfeeding has not been established through clinical trials.